Precigen (PGEN) Accounts Payables (2012 - 2026)
Precigen (PGEN) posted quarterly Accounts Payables of $2.6 million for Q1 2026, down 16.67% year-over-year from $3.1 million in Q1 2025, and down 78.4% quarter-over-quarter from $12.0 million in Q4 2025.
Precigen (PGEN) Accounts Payables (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Accounts Payables for 15 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables fell 16.67% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (down 16.67% YoY), while the FY2025 annual figure was $12.0 million, up 239.42% from the prior year.
- Accounts Payables declined to $2.6 million in Q1 2026 per PGEN's latest filing, from $12.0 million in the prior quarter.
- Across five years, Accounts Payables topped out at $12.0 million in Q4 2025 and bottomed at $1.7 million in Q4 2023.
- Historically, Accounts Payables has averaged $4.2 million across 5 years, with a median of $3.9 million in 2025.
- Annual changes were most pronounced in 2023 — Accounts Payables sank 57.57% — and 2025, when it jumped 239.42%.
- Precigen's Accounts Payables stood at $4.1 million in 2022, then tumbled by 57.57% to $1.7 million in 2023, then surged by 104.58% to $3.5 million in 2024, then surged by 239.42% to $12.0 million in 2025, then slumped by 78.4% to $2.6 million in 2026.
- Business Quant data shows PGEN's Accounts Payables at $2.6 million in Q1 2026, $12.0 million in Q4 2025, and $6.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Precigen | 2.18 Bn | 2.18 Bn | 52.17 Mn | 5.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.30 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 11.99 Mn |
| Sep 30, 2025 | 6.26 Mn |
| Jun 30, 2025 | 3.92 Mn |
| Mar 31, 2025 | 3.11 Mn |
| Dec 31, 2024 | 3.53 Mn |
| Sep 30, 2024 | 4.32 Mn |
| Jun 30, 2024 | 4.85 Mn |
| Mar 31, 2024 | 4.72 Mn |
| Dec 31, 2023 | 1.73 Mn |
| Sep 30, 2023 | 2.35 Mn |
| Jun 30, 2023 | 2.51 Mn |
| Mar 31, 2023 | 3.81 Mn |
| Dec 31, 2022 | 4.07 Mn |
| Sep 30, 2022 | 4.20 Mn |
| Jun 30, 2022 | 2.67 Mn |
| Mar 31, 2022 | 4.42 Mn |
| Dec 31, 2021 | 3.11 Mn |
| Sep 30, 2021 | 3.62 Mn |